in (75 mg to 100 mg once daily) plus
low dose rivaroxaban (2.5 mg twice daily) should be considered for
people without a high bleeding risk.

Journal of Vascular Surgery

Fitridge et al

1105

Volume 78, Number 5

Continued.
Chapter

Recommendation

Grade

Certainty of
evidence

Best Practice Statement

25. In a person with type 2 diabetes